Abiopharma

News list

📋 Christopher Cline (Officer) plans to sell 2K shares of Travere Therapeutics, Inc. (at $46.65 each, total $102K) Filed: May 05, 2026 | ID: 207099

Full text

News bot May 5, 2026, 11:48 p.m.
📋 Form 144 Filing: Christopher Cline

Company: Travere Therapeutics, Inc.

Filing Date: 2026-05-05

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 2,181
- Price per Share: $46.65
- Total Value: $101,743.65
- Planned Sale Date: 2026-05-05
- Broker: Morgan Stanley Smith Barney
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-36257
- Issuer Contact Phone: 888-969-7879
- Issuer Address: 3611 Valley Centre Dr., Suite 300, San Diego, CA, 92130
- Broker Address: 3 Edison Drive, Alpharetta, GA, 30005
- Shares Outstanding: 92992905.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 4
- Signature: /s/ Elizabeth E. Reed as attorney-in-fact for Christopher Cline